Expression of Toll-Like Receptors 2, 4 and 9 in Patients with Guillain-Barre Syndrome

被引:26
作者
Wang, Yu-Zhong [1 ]
Liang, Qiu-Hua [2 ]
Ramkalawan, Hhoonisha [1 ]
Wang, Yan-Li [1 ]
Yang, Yan-Fang [1 ]
Zhou, Wen-Bin [1 ]
Tian, Fa-Fa [1 ]
Li, Jing [1 ]
Yang, Huan [1 ]
机构
[1] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China
[2] Cent S Univ, Hosp Xiangya 2, Inst Endocrinol & Metab, Changsha 410008, Hunan, Peoples R China
关键词
Guillain-Barre syndrome; Innate immunity; Toll-like receptor; Signaling pathway; Cytokine; EXPERIMENTAL AUTOIMMUNE NEURITIS; PERIPHERAL-NERVE; NEGATIVE REGULATION; IMMUNE REGULATION; CYTOKINE; ACTIVATION; CELLS; GAMMA; SOCS; RAT;
D O I
10.1159/000328200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A myriad of transcription factors and inflammatory cytokines have been described to participate in the pathogenesis of Guillain-Barre syndrome (GBS). However, the innate immunity components - Toll-like receptors (TLRs) - have never been explored in this disease. We therefore investigated the expression of TLR2, 4 and 9 in the peripheral circulation of GBS patients as well as healthy controls. Methods: Twenty-one GBS patients and 21 healthy donors participated in this study. Peripheral blood mononuclear cells were used for mRNA and protein analysis of TLR-related molecules. Also, peripheral blood mononuclear cells from different subjects were incubated with different TLR agonists and the subsequent IFN-gamma secretion was determined. Results: Expression of TLR2, 4 and 9 as well as their related signaling molecules were higher in GBS patients compared to healthy controls. Disability scores of GBS patients had a strong positive correlation with the high levels of expression of TLR2, 4 and 9. Conclusions: The TLR signaling pathway may be involved in the pathogenesis of GBS. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:60 / 68
页数:9
相关论文
共 31 条
  • [1] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [2] Guillain-Barre syndrome
    Burns, Ted M.
    [J]. SEMINARS IN NEUROLOGY, 2008, 28 (02) : 152 - 167
  • [3] CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
    Chu, RS
    Targoni, OS
    Krieg, AM
    Lehmann, PV
    Harding, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) : 1623 - 1631
  • [4] Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
  • [5] Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis
    Deng, Yong-Ning
    Zhou, Wen-Bin
    [J]. NEUROIMMUNOMODULATION, 2008, 14 (06) : 337 - 343
  • [6] Gold R, 1999, BRAIN PATHOL, V9, P343
  • [7] Autoimmune responses in peripheral nerve
    Hartung, HP
    Willison, H
    Jung, S
    Pette, M
    Toyka, KV
    Giegerich, G
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1996, 18 (01): : 97 - 123
  • [8] Twenty proteins containing a C-terminal SOCS box form five structural classes
    Hilton, DJ
    Richardson, RT
    Alexander, WS
    Viney, EM
    Willson, TA
    Sprigg, NS
    Starr, R
    Nicholson, SE
    Metcalf, D
    Nicola, NA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) : 114 - 119
  • [9] The spectrum of antecedent infections in Guillain-Barre syndrome -: A case-control study
    Jacobs, BC
    Rothbarth, PH
    van der Meché, FGA
    Herbrink, P
    Schmitz, PIM
    de Klerk, MA
    van Doorn, PA
    [J]. NEUROLOGY, 1998, 51 (04) : 1110 - 1115
  • [10] SOCS1/JAB is a negative regulator of LPS-induced macrophage activation
    Kinjyo, I
    Hanada, T
    Inagaki-Ohara, K
    Mori, H
    Aki, D
    Ohishi, M
    Yoshida, H
    Kubo, M
    Yoshimura, A
    [J]. IMMUNITY, 2002, 17 (05) : 583 - 591